These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16020027)

  • 1. Implications of chronic methamphetamine use: a literature review.
    Meredith CW; Jaffe C; Ang-Lee K; Saxon AJ
    Harv Rev Psychiatry; 2005; 13(3):141-54. PubMed ID: 16020027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?
    Fernández-Serrano MJ; Pérez-García M; Verdejo-García A
    Neurosci Biobehav Rev; 2011 Jan; 35(3):377-406. PubMed ID: 20451551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection.
    Carey CL; Woods SP; Rippeth JD; Gonzalez R; Heaton RK; Grant I
    AIDS Behav; 2006 Mar; 10(2):185-90. PubMed ID: 16477511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticolimbic dysregulation and chronic methamphetamine abuse.
    Baicy K; London ED
    Addiction; 2007 Apr; 102 Suppl 1():5-15. PubMed ID: 17493049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
    Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
    Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.
    Bora E; Yucel M; Pantelis C
    J Affect Disord; 2009 Feb; 113(1-2):1-20. PubMed ID: 18684514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention.
    Yücel M; Lubman DI
    Drug Alcohol Rev; 2007 Jan; 26(1):33-9. PubMed ID: 17364834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic treatment in schizophrenia: the role of computerized neuropsychological assessment.
    Kertzman S; Reznik I; Grinspan H; Weizman A; Kotler M
    Isr J Psychiatry Relat Sci; 2008; 45(2):114-20. PubMed ID: 18982837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications.
    Homer BD; Solomon TM; Moeller RW; Mascia A; DeRaleau L; Halkitis PN
    Psychol Bull; 2008 Mar; 134(2):301-10. PubMed ID: 18298273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on substance use and treatment following traumatic brain injury.
    Graham DP; Cardon AL
    Ann N Y Acad Sci; 2008 Oct; 1141():148-62. PubMed ID: 18991956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.
    Panenka WJ; Procyshyn RM; Lecomte T; MacEwan GW; Flynn SW; Honer WG; Barr AM
    Drug Alcohol Depend; 2013 May; 129(3):167-79. PubMed ID: 23273775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine users in the psychiatric emergency services: a case-control study.
    Pasic J; Russo JE; Ries RK; Roy-Byrne PP
    Am J Drug Alcohol Abuse; 2007; 33(5):675-86. PubMed ID: 17891660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropsychological aspects of the manic syndrome in the course of bipolar affective illness].
    Lewandowska A; Rybakowski J
    Psychiatr Pol; 2009; 43(3):275-86. PubMed ID: 19725421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment response by primary drug of abuse: does methamphetamine make a difference?
    Luchansky B; Krupski A; Stark K
    J Subst Abuse Treat; 2007 Jan; 32(1):89-96. PubMed ID: 17175402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Findings of preserved implicit attention in methamphetamine dependent subjects.
    Salo R; Leamon MH; Natsuaki Y; Moore C; Waters C; Nordahl TE
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):217-23. PubMed ID: 17870223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in Aboriginal people with heavy episodic patterns of alcohol use.
    Cairney S; Clough A; Jaragba M; Maruff P
    Addiction; 2007 Jun; 102(6):909-15. PubMed ID: 17523985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attentional control and brain metabolite levels in methamphetamine abusers.
    Salo R; Nordahl TE; Natsuaki Y; Leamon MH; Galloway GP; Waters C; Moore CD; Buonocore MH
    Biol Psychiatry; 2007 Jun; 61(11):1272-80. PubMed ID: 17097074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.